Literature DB >> 9622487

Role of the colchicine ring A and its methoxy groups in the binding to tubulin and microtubule inhibition.

J M Andreu1, B Perez-Ramirez, M J Gorbunoff, D Ayala, S N Timasheff.   

Abstract

The roles of the methoxy substituents on ring A of two ring colchicine (COL) analogues were probed by the synthesis of a number of drugs and the examination of their effect on binding to tubulin, inhibition of microtubule assembly, and induction of GTPase activity. Selective elimination of ring A methoxy groups at positions 2, 3, and 4 weakened all three processes. The effects on binding and inhibition were independent of the nature of ring C (or C'). Specifically, excision of the 2- or 3-methoxy groups weakened binding by ca. 0.4 kcal mol-1, while that of the 4-methoxy group of ring A was weakened by 1.36 +/- 0.15 kcal mol-1. The effect on the inhibition of microtubule assembly, expressed as the equilibrium constant for the binding of the tubulin-drug complex to the end of a microtubule, was more complex and strongly dependent on the nature of ring C (or C'). This was attributed to the abilities of various groups on ring C' to overcome the wobbling in the tubulin-drug complex introduced by the weakening of the anchoring provided by ring A. It is concluded that ring A of COL is not germane to the mechanism of the inhibition of tubulin self-assembly. It serves only as a complex-stabilizing anchor. The control of this process resides in the interactions that key oxygen atoms of ring C of COL or C' of structural analogues establish with the protein. It is proposed that the 4-methoxy group of ring A serves as a key attachment point for immobilization of the drugs on the protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622487     DOI: 10.1021/bi9728553

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Characterization of the colchicine binding site on avian tubulin isotype betaVI.

Authors:  Shubhada Sharma; Barbara Poliks; Colby Chiauzzi; Rudravajhala Ravindra; Adam R Blanden; Susan Bane
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

2.  Pyrrole-Based Antitubulin Agents: Two Distinct Binding Modalities are Predicted for C-2 Analogs in the Colchicine Site.

Authors:  Chenxiao Da; Nakul Telang; Peter Barelli; Xin Jia; John T Gupton; Susan L Mooberry; Glen E Kellogg
Journal:  ACS Med Chem Lett       Date:  2011-11-01       Impact factor: 4.345

3.  Stathmin and interfacial microtubule inhibitors recognize a naturally curved conformation of tubulin dimers.

Authors:  Pascale Barbier; Audrey Dorléans; Francois Devred; Laura Sanz; Diane Allegro; Carlos Alfonso; Marcel Knossow; Vincent Peyrot; Jose M Andreu
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

4.  Bacterial tubulin distinct loop sequences and primitive assembly properties support its origin from a eukaryotic tubulin ancestor.

Authors:  Antonio J Martin-Galiano; María A Oliva; Laura Sanz; Anamitra Bhattacharyya; Marina Serna; Hugo Yebenes; Jose M Valpuesta; Jose M Andreu
Journal:  J Biol Chem       Date:  2011-04-04       Impact factor: 5.157

5.  A tribute to Dr. Serge N. Timasheff, our mentor.

Authors:  Kirk Aune; James Lee; V Prakash; Rajiv Bhat; Jose Andreu; Octavio Monasterio; Bernardo Perez-Ramirez; Keith Shearwin; Tsutomu Arakawa; John Carpenter; John Crowe; Lois Crowe; George Somero; Pete Gagnon; Marina Timasheff Charles
Journal:  Biophys Rev       Date:  2021-07-06

6.  How to deal with low-resolution target structures: using SAR, ensemble docking, hydropathic analysis, and 3D-QSAR to definitively map the αβ-tubulin colchicine site.

Authors:  Chenxiao Da; Susan L Mooberry; John T Gupton; Glen E Kellogg
Journal:  J Med Chem       Date:  2013-09-09       Impact factor: 7.446

7.  Methoxy and bromo scans on N-(5-methoxyphenyl) methoxybenzenesulphonamides reveal potent cytotoxic compounds, especially against the human breast adenocarcinoma MCF7 cell line.

Authors:  Myriam González; María Ovejero-Sánchez; Alba Vicente-Blázquez; Manuel Medarde; Rogelio González-Sarmiento; Rafael Peláez
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

8.  A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo.

Authors:  Yi-Wen Wu; Kai-Cheng Hsu; Hsueh-Yun Lee; Tsui-Chin Huang; Tony E Lin; Yi-Ling Chen; Ting-Yi Sung; Jing-Ping Liou; Wendy W Hwang-Verslues; Shiow-Lin Pan; Wei-Chun HuangFu
Journal:  Front Pharmacol       Date:  2018-03-13       Impact factor: 5.810

9.  Targeted Nano-Drug Delivery of Colchicine against Colon Cancer Cells by Means of Mesoporous Silica Nanoparticles.

Authors:  Khaled AbouAitah; Heba A Hassan; Anna Swiderska-Sroda; Lamiaa Gohar; Olfat G Shaker; Jacek Wojnarowicz; Agnieszka Opalinska; Julita Smalc-Koziorowska; Stanislaw Gierlotka; Witold Lojkowski
Journal:  Cancers (Basel)       Date:  2020-01-07       Impact factor: 6.639

10.  The colchicine derivative CT20126 shows a novel microtubule-modulating activity with apoptosis.

Authors:  Sung-Kuk Kim; Sang-Min Cho; Ho Kim; Heon Seok; Soon-Ok Kim; Taeg Kyu Kwon; Jong-Soo Chang
Journal:  Exp Mol Med       Date:  2013-04-19       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.